靶向肿瘤坏死因子相关凋亡诱导配体（TRAIL）通路的疗法。
TRAIL pathway targeting therapeutics.
作者信息
Ralff Marie D, El-Deiry Wafik S
机构信息
MD/PhD Program, Lewis Katz School of Medicine, Temple University, Philadelphia, PA.
Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Hematology/Oncology and Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA.
出版信息
Expert Rev Precis Med Drug Dev. 2018;3(3):197-204. doi: 10.1080/23808993.2018.1476062. Epub 2018 May 28.
Abstract
INTRODUCTION
Despite decades of focused research efforts, cancer remains a significant cause of morbidity and mortality. Tumor necrosis factor(TNF)-related apoptosis-inducing ligand (TRAIL) is capable of inducing cell death selectively in cancer cells while sparing normal cells.
AREAS COVERED
In this review, the authors cover TRA therapy and strategies that have been undertaken to improve their efficacy, as well as unconventional approaches to TRAIL pathway activation including TRAIL-inducing small molecules. They also discuss mechanisms of resistance to TRAIL and the use of combination strategies to overcome it.
EXPERT COMMENTARY
Targeting the TRAIL pathway has been of interest in oncology, and although initial clinical trials of TRAIL receptor agonists (TRAs) showed limitations, novel approaches represent the future of TRAIL-based therapy.
摘要
引言
尽管经过数十年的专注研究努力，癌症仍然是发病和死亡的重要原因。肿瘤坏死因子（TNF）相关凋亡诱导配体（TRAIL）能够在癌细胞中选择性地诱导细胞死亡，同时使正常细胞免受影响。
涵盖领域
在本综述中，作者涵盖了TRAIL疗法以及为提高其疗效而采取的策略，以及TRAIL途径激活的非常规方法，包括诱导TRAIL的小分子。他们还讨论了对TRAIL的耐药机制以及使用联合策略来克服它。
专家评论
靶向TRAIL途径一直是肿瘤学领域感兴趣的内容，尽管TRAIL受体激动剂（TRAs）的初步临床试验显示出局限性，但新方法代表了基于TRAIL治疗的未来。
相似文献
1
TRAIL pathway targeting therapeutics.靶向肿瘤坏死因子相关凋亡诱导配体（TRAIL）通路的疗法。
Expert Rev Precis Med Drug Dev. 2018;3(3):197-204. doi: 10.1080/23808993.2018.1476062. Epub 2018 May 28.
2
Targeting TRAIL in the treatment of cancer: new developments.靶向TRAIL用于癌症治疗：新进展
Expert Opin Ther Targets. 2015;19(9):1171-85. doi: 10.1517/14728222.2015.1049838. Epub 2015 May 25.
3
Targeting TRAIL death receptor 4 with trivalent DR4 Atrimer complexes.用三价 DR4 Atrimer 复合物靶向 TRAIL 死亡受体 4。
Mol Cancer Ther. 2012 Oct;11(10):2087-95. doi: 10.1158/1535-7163.MCT-12-0366. Epub 2012 Jul 16.
4
Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy.我们应该继续沿着胰腺癌治疗之路前行吗？重新审视用于抗癌治疗的肿瘤坏死因子相关凋亡诱导配体。
Cancers (Basel). 2018 Mar 18;10(3):77. doi: 10.3390/cancers10030077.
5
Therapeutic targeting of TRAIL death receptors.TRAIL 死亡受体的治疗靶向。
Biochem Soc Trans. 2023 Feb 27;51(1):57-70. doi: 10.1042/BST20220098.
6
Inducible resistance of tumor cells to tumor necrosis factor-related apoptosis-inducing ligand receptor 2-mediated apoptosis by generation of a blockade at the death domain function.肿瘤细胞通过在死亡结构域功能上产生阻断作用，对肿瘤坏死因子相关凋亡诱导配体受体2介导的凋亡产生诱导性抗性。
Cancer Res. 2006 Sep 1;66(17):8520-8. doi: 10.1158/0008-5472.CAN-05-4364.
7
Getting TRAIL back on track for cancer therapy.让TRAIL在癌症治疗的道路上重回正轨。
Cell Death Differ. 2014 Sep;21(9):1350-64. doi: 10.1038/cdd.2014.81. Epub 2014 Jun 20.
8
TRAILblazing Strategies for Cancer Treatment.癌症治疗的开创性策略。
Cancers (Basel). 2019 Mar 30;11(4):456. doi: 10.3390/cancers11040456.
9
TRAIL receptor signalling and modulation: Are we on the right TRAIL?肿瘤坏死因子相关凋亡诱导配体（TRAIL）受体信号传导与调节：我们是否选对了TRAIL？
Cancer Treat Rev. 2009 May;35(3):280-8. doi: 10.1016/j.ctrv.2008.11.006. Epub 2008 Dec 30.
10
Safety and tolerability of TRAIL receptor agonists in cancer treatment.TRAIL受体激动剂在癌症治疗中的安全性和耐受性。
Eur J Clin Pharmacol. 2015 May;71(5):525-7. doi: 10.1007/s00228-015-1823-1. Epub 2015 Feb 24.
引用本文的文献
1
Piezo1-related physiological and pathological processes in glioblastoma.胶质母细胞瘤中与Piezo1相关的生理和病理过程。
Front Cell Dev Biol. 2025 Feb 21;13:1536320. doi: 10.3389/fcell.2025.1536320. eCollection 2025.
2
Ashwagandha-Induced Programmed Cell Death in the Treatment of Breast Cancer.印度人参诱导的程序性细胞死亡在乳腺癌治疗中的作用
Curr Issues Mol Biol. 2024 Jul 18;46(7):7668-7685. doi: 10.3390/cimb46070454.
3
The Role of TRAIL Signaling in Cancer: Searching for New Therapeutic Strategies.TRAIL信号通路在癌症中的作用：探寻新的治疗策略
Biology (Basel). 2024 Jul 15;13(7):521. doi: 10.3390/biology13070521.
4
Combining the constitutive TRAIL-secreting induced neural stem cell therapy with the novel anti-cancer drug TR-107 in glioblastoma.将组成型分泌肿瘤坏死因子相关凋亡诱导配体的诱导神经干细胞疗法与新型抗癌药物TR-107联合用于胶质母细胞瘤治疗。
Mol Ther Oncol. 2024 Jun 15;32(3):200834. doi: 10.1016/j.omton.2024.200834. eCollection 2024 Sep 19.
5
Rolapitant treats lung cancer by targeting deubiquitinase OTUD3.罗哌司他通过靶向去泛素化酶 OTUD3 治疗肺癌。
Cell Commun Signal. 2024 Mar 27;22(1):195. doi: 10.1186/s12964-024-01519-8.
6
The role of the immune response and inflammatory pathways in TNF-related apoptosis-inducing ligand (TRAIL) resistance in triple-negative breast cancer cells.免疫反应和炎症通路在三阴性乳腺癌细胞中肿瘤坏死因子相关凋亡诱导配体（TRAIL）抗性中的作用。
Am J Cancer Res. 2023 Oct 15;13(10):4678-4692. eCollection 2023.
7
The role of p53 in anti-tumor immunity and response to immunotherapy.p53在抗肿瘤免疫及免疫治疗反应中的作用。
Front Mol Biosci. 2023 Aug 1;10:1148389. doi: 10.3389/fmolb.2023.1148389. eCollection 2023.
8
Tubeimoside-1 Enhances TRAIL-Induced Apoptotic Cell Death through STAMBPL1-Mediated c-FLIP Downregulation.管花苷-1 通过 STAMBPL1 介导的 c-FLIP 下调增强 TRAIL 诱导的细胞凋亡。
Int J Mol Sci. 2023 Jul 24;24(14):11840. doi: 10.3390/ijms241411840.
9
The Role of TRAIL in Apoptosis and Immunosurveillance in Cancer.TRAIL在癌症细胞凋亡和免疫监视中的作用
Cancers (Basel). 2023 May 13;15(10):2752. doi: 10.3390/cancers15102752.
10
Chemical Activation and Mechanical Sensitization of Piezo1 Enhance TRAIL-Mediated Apoptosis in Glioblastoma Cells.Piezo1的化学激活和机械敏化增强了TRAIL介导的胶质母细胞瘤细胞凋亡。
ACS Omega. 2023 May 3;8(19):16975-16986. doi: 10.1021/acsomega.3c00705. eCollection 2023 May 16.
本文引用的文献
1
Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitment.增强 TRAIL 诱导剂 ONC201 的剂量可抑制转移并促进肿瘤内 NK 细胞募集。
J Clin Invest. 2018 Jun 1;128(6):2325-2338. doi: 10.1172/JCI96711. Epub 2018 Apr 30.
2
Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors.癌症干细胞相关基因表达作为新型咪哌啶酮ONC201在实体瘤中反应的潜在生物标志物。
PLoS One. 2017 Aug 2;12(8):e0180541. doi: 10.1371/journal.pone.0180541. eCollection 2017.
3
Preclinical evaluation of the imipridone family, analogs of clinical stage anti-cancer small molecule ONC201, reveals potent anti-cancer effects of ONC212.临床阶段抗癌小分子 ONC201 的类似物 imipridone 家族的临床前评估显示 ONC212 具有强大的抗癌作用。
Cell Cycle. 2017 Oct 2;16(19):1790-1799. doi: 10.1080/15384101.2017.1325046. Epub 2017 May 10.
4
ONC201 Demonstrates Antitumor Effects in Both Triple-Negative and Non-Triple-Negative Breast Cancers through TRAIL-Dependent and TRAIL-Independent Mechanisms.ONC201通过依赖TRAIL和不依赖TRAIL的机制在三阴性和非三阴性乳腺癌中均表现出抗肿瘤作用。
Mol Cancer Ther. 2017 Jul;16(7):1290-1298. doi: 10.1158/1535-7163.MCT-17-0121. Epub 2017 Apr 19.
5
First-in-Human Clinical Trial of Oral ONC201 in Patients with Refractory Solid Tumors.口服ONC201用于难治性实体瘤患者的首次人体临床试验。
Clin Cancer Res. 2017 Aug 1;23(15):4163-4169. doi: 10.1158/1078-0432.CCR-16-2658. Epub 2017 Mar 22.
6
The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2.肿瘤坏死因子相关凋亡诱导配体（TRAIL）诱导的癌症分泌组通过CCR2促进肿瘤支持性免疫微环境。
Mol Cell. 2017 Feb 16;65(4):730-742.e5. doi: 10.1016/j.molcel.2017.01.021.
7
Caspase-8 Acts in a Non-enzymatic Role as a Scaffold for Assembly of a Pro-inflammatory "FADDosome" Complex upon TRAIL Stimulation.Caspase-8 在 TRAIL 刺激下作为组装促炎“FADDosome”复合物的支架发挥非酶活性作用。
Mol Cell. 2017 Feb 16;65(4):715-729.e5. doi: 10.1016/j.molcel.2017.01.022.
8
Onto better TRAILs for cancer treatment.探索更好的肿瘤坏死因子相关凋亡诱导配体用于癌症治疗。
Cell Death Differ. 2016 May;23(5):733-47. doi: 10.1038/cdd.2015.174. Epub 2016 Mar 4.
9
ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2α kinases.ONC201通过触发一种依赖于特定eIF2α激酶激活ATF4的综合应激反应来杀死实体瘤细胞。
Sci Signal. 2016 Feb 16;9(415):ra18. doi: 10.1126/scisignal.aac4374.
10
ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies.通过对ONC201的非典型综合应激反应诱导ATF4可引发血液系统恶性肿瘤中不依赖p53的凋亡。
Sci Signal. 2016 Feb 16;9(415):ra17. doi: 10.1126/scisignal.aac4380.
Zotero 插件